{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:40:18Z","timestamp":1758937218070,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.leukres.2021.106651","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T04:10:12Z","timestamp":1624939812000},"page":"106651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study"],"prefix":"10.1016","volume":"107","author":[{"given":"Richa","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad","family":"Dange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haraparasad","family":"Pati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.leukres.2021.106651_bib0005","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.leukres.2021.106651_bib0010","first-page":"1168","article-title":"Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes","volume":"90","author":"Sol\u00e9","year":"2005","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.leukres.2021.106651_bib0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00277-008-0483-y","article-title":"Cytogenetic features in myelodysplastic syndromes","volume":"87","author":"Haase","year":"2008","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106651_bib0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2000.01868.x","article-title":"Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espa\u00f1ol de Citogen\u00e9tica Hematol\u00f3gica","volume":"108","author":"Sol\u00e9","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106651_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk. Res."},{"issue":"7","key":"10.1016\/j.leukres.2021.106651_bib0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2009.02151.x","article-title":"Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions","volume":"39","author":"Valent","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"issue":"43","key":"10.1016\/j.leukres.2021.106651_bib0035","doi-asserted-by":"crossref","first-page":"73483","DOI":"10.18632\/oncotarget.19008","article-title":"Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions","volume":"8","author":"Valent","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.leukres.2021.106651_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cyto.b.21089","article-title":"Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes","volume":"84","author":"Xu","year":"2013","journal-title":"Cytometry B Clin. Cytom."},{"issue":"4","key":"10.1016\/j.leukres.2021.106651_bib0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood.V98.4.979","article-title":"Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome","volume":"98","author":"Stetler-Stevenson","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2021.106651_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088706","article-title":"Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.leukres.2021.106651_bib0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2009.008532","article-title":"Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study","volume":"94","author":"Ogata","year":"2009","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2021.106651_bib0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.leu.2403680","article-title":"Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome","volume":"19","author":"Malcovati","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.leukres.2021.106651_bib0065","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00277-012-1461-y","article-title":"Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches","volume":"91","author":"Chopra","year":"2012","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2021.106651_bib0070","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2021.106651_bib0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.leukres.2011.11.005","article-title":"Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop","volume":"36","author":"Platzbecker","year":"2012","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.leukres.2021.106651_bib0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/10428194.2012.718341","article-title":"Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group","volume":"54","author":"van de Loosdrecht","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2021.106651_bib0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"year":"2017","series-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissue","author":"Swerdlow","key":"10.1016\/j.leukres.2021.106651_bib0090"},{"issue":"2","key":"10.1016\/j.leukres.2021.106651_bib0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.leukres.2006.04.010","article-title":"Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders","volume":"31","author":"Lorand-Metze","year":"2007","journal-title":"Leuk. Res."},{"issue":"19","key":"10.1016\/j.leukres.2021.106651_bib0100","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.25353","article-title":"Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data","volume":"116","author":"Kern","year":"2010","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2021.106651_bib0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1600-0609.2011.01676.x","article-title":"Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes","volume":"87","author":"Falco","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106651_bib0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.leukres.2007.06.012","article-title":"Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls","volume":"32","author":"Stachurski","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2021.106651_bib0115","first-page":"7","article-title":"The use of flow cytometry in myelodysplastic syndromes: a review","author":"Bento","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.leukres.2021.106651_bib0120","first-page":"6","article-title":"Diagnostic utility of flow cytometry in myelodysplastic syndromes","author":"Aanei","year":"2016","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2021.106651_bib0125","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3109\/10428194.2013.781167","article-title":"Immunophenotypic profile of nucleated erythroid progenitors during maturation in regenerating bone marrow","volume":"54","author":"Fajtova","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2021.106651_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.leukres.2018.07.009","article-title":"Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: introducing a parameter quantifying CD33 expression on CD34+ cells","volume":"71","author":"Ogata","year":"2018","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.leukres.2021.106651_bib0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cyto.b.21233","article-title":"Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube","volume":"88","author":"Rajab","year":"2015","journal-title":"Cytometry B Clin. Cytom."},{"issue":"6","key":"10.1016\/j.leukres.2021.106651_bib0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ijlh.12700","article-title":"A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes","volume":"39","author":"K\u00e1rai","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106651_bib0145","first-page":"29","article-title":"Utility of a single-tube, six-color flow cytometry panel for the diagnosis of myelodysplastic syndrome: experience of a tertiary care centre in India","volume":"12","author":"Gupta","year":"2018","journal-title":"Int. J. Hematol-Oncol Stem Cell Res"},{"issue":"1","key":"10.1016\/j.leukres.2021.106651_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cyto.b.21725","article-title":"Immunophenotypic profile of CD34+ subpopulations and their role in the diagnosis and prognosis of patients with de-novo, particularly low-grade myelodysplastic syndromes","volume":"96","author":"Gardikas","year":"2019","journal-title":"Cytometry B Clin. Cytom."},{"issue":"20","key":"10.1016\/j.leukres.2021.106651_bib0155","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2021.106651_bib0160","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.leukres.2021.106651_bib0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cyto.b.21519","article-title":"Visualization of Cell Composition and Maturation in the Bone Marrow Using 10\u2010Color Flow Cytometry and Radar Plots","volume":"94","author":"Jafari","year":"2018","journal-title":"Cytometry B Clin. Cytom."},{"issue":"4","key":"10.1016\/j.leukres.2021.106651_bib0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hon.857","article-title":"Diagnostic flow cytometry for low-grade myelodysplastic syndromes","volume":"26","author":"Ogata","year":"2008","journal-title":"Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106651_bib0175","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2141.2010.08146.x","article-title":"Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes","volume":"149","author":"Xu","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106651_bib0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cyto.b.20041","article-title":"Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes","volume":"64B","author":"Cherian","year":"2005","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.leukres.2021.106651_bib0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejca.2015.11.013","article-title":"Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias","volume":"54","author":"Cremers","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.leukres.2021.106651_bib0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.leukres.2019.01.009","article-title":"Flow cytometry diagnosis in myelodysplastic syndrome: current practice in Latin America and comparison with other regions of the world","volume":"79","author":"Grille","year":"2019","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.leukres.2021.106651_bib0195","first-page":"166","article-title":"Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia","volume":"24","author":"Muyldermans","year":"2019","journal-title":"Hematol Amst Neth"},{"issue":"2","key":"10.1016\/j.leukres.2021.106651_bib0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/ijlh.12458","article-title":"Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome","volume":"38","author":"Somasundaram","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2021.106651_bib0205","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/leu.2015.295","article-title":"The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system","volume":"30","author":"Alhan","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2021.106651_bib0210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cyto.b.21843","article-title":"Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1\u2010tube panel strategy for diagnosis and prognosis of patients with MDS","volume":"98","author":"Barreau","year":"2020","journal-title":"Cytometry B Clin. Cytom."},{"issue":"S1","key":"10.1016\/j.leukres.2021.106651_bib0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/ijlh.12368","article-title":"Flow cytometry immunophenotyping in integrated diagnostics of patients with newly diagnosed cytopenia: one tube 10-color 14-antibody screening panel and 3-tube extensive panel for detection of MDS-related features","volume":"37","author":"Porwit","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106651_bib0220","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/ijlh.13047","article-title":"Flow cytometry \u201cOgata score\u201d for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience","volume":"41","author":"Grille Montauban","year":"2019","journal-title":"Int J Lab Hematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:27Z","timestamp":1758934887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":44,"alternative-id":["S0145212621001521"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106651","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106651"}}